US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Quasi-New Stocks

681.27

+15.522.33%

Number of Gainers:86

Number of Losers:55

Number of Flat:12

PE:- -

High:685.36

Open:665.86

Low:665.84

Close:665.74

Volume:336.25M

Turnover:9.60B

Market Cap:470.12B

Float Cap:361.90B

Loading ...

Viridian Therapeutics' Lumvoa Off to 'Stronger Start' Than Anticipated, RBC Says

MT Newswires Live

Coinbase Flags AVAX Transfer Delays Ahead of Scheduled Avalanche Network Upgrade

Coinbase: Some Users May Experience Delays in Sends and Receives of Avalanche (Avax) Due to a Scheduled Network Upgrade

THOMSON REUTERS

RxSight is Maintained at Hold by Jefferies

Qyuns Therapeutics Updates Board Composition and Governance Structure

Qyuns Therapeutics Raises QX001S Deal Caps and Refreshes Board Line-Up

IPOWER Stockholders Approve Capital and Incentive Changes

Global-E Online President Debbi Nir Disposes of 8,332 Common Shares Worth $307,385.61

Viking Therapeutics Surges Nearly 50% Premarket as Once-Every-Two-Week Dosing Retains 97% of Weight Loss

Nexxen U Launches ‘Data for the Converged Media World,’ Building on Program Momentum and Industry Demand

Forvis Mazars Capital Advisors Selects Intapp DealCloud with Celeste for Deal Workflow Automation

Forvis Mazars Capital Advisors Selects Intapp Dealcloud with Celeste to Advance Firmwide Agentic AI Strategy

THOMSON REUTERS

iPower Shareholders Approve $10 Million Common Stock Issuance at Special Meeting

BofA Adjusts Price Target on RxSight to $5.50 From $6.50

MT Newswires Live

Aprea Therapeutics to Present Updated Interim Phase 1 Data on WEE1 Inhibitor APR-1051 in an Oral Presentation at 38th EORTC-NCI-AACR Symposium

Marker Therapeutics highlights expanded manufacturing support of CDMO partner

Transcode Therapeutics - Announces Patent Advancements in Australia and Japan for Rna Platform

THOMSON REUTERS

Zeta Global Names Lalitha Stables President, UK

TransCode Therapeutics Says Australia Accepts Patent Application for siRNA Cancer Nanoparticle Delivery

Zeta Global Invests in U.k. Growth with New London Hub and Leadership

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigeractivity.com/stock/BK4539/news?page=38"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK4539","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","market":"US","secType":"PLATE","nameCN":"Quasi-New Stocks","latestPrice":681.2682,"timestamp":1791230399999,"preClose":665.74475,"halted":0,"volume":336253743,"delay":0,"changeRate":0.023317,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":15.523438,"latestTime":"10-05 16:00:00 EDT","open":665.858,"high":685.3558,"low":665.84424,"amount":9595190799.618418,"amplitude":0.029308,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1791244800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.17484,"peRate":114.229173,"turnoverRate":0.026371,"increases":86,"decrements":55,"flats":9,"marketCap":470115621631,"floatMarketCap":361902936583},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","high":685.3558,"amplitude":0.029308,"preClose":665.74475,"low":665.84424,"pbRate":"5.17484","latestPrice":681.2682,"volume":336253743,"delay":0,"open":665.858,"prevYearClose":881.5255,"prevWeekClose":665.7447,"prevMonthClose":677.2829,"prevQuarterClose":677.2829,"fiveDayClose":688.6523,"twentyDayClose":725.2816,"sixtyDayClose":769.1713,"secType":"PLATE","market":"US","turnoverRate":0.026371,"peRate":114.229173,"marketCap":470115621631,"floatMarketCap":361902936583,"timestamp":1791230399999,"nameCN":"Quasi-New Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4539\",,,,undefined,":{"bkCode":"BK4539","up":86,"down":55,"flat":12},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4539\",pageSize:20,pageCount:38,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2669072123","title":"Viridian Therapeutics' Lumvoa Off to 'Stronger Start' Than Anticipated, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2669072123","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669072123?lang=en_us&edition=fundamental","pubTime":"2026-09-22 23:45","pubTimestamp":1790091902,"startTime":"0","endTime":"0","summary":"Viridian Therapeutics'  Lumvoa is off to a \"stronger start\" than anticipated, RBC Capital Markets said in a Tuesday note.RBC analysts talked with six key opinion leaders about the drug, which treats Thyroid Eye Disease, and discovered that it has had good early uptake so far. Half of the doctors have written at least one prescription for the drug since its launch on June 26, and a third have reported infusing at least one patient, the analysts noted.The evidence of early adoption suggests that physicians are enthusiastic about gaining experience with Lumvoa and seeing how it stacks up against competing treatment Tepezza on efficacy and safety, the analysts said.Rather than clinical reluctance, the main headwind for Lumvoa in the near term is challenges with access; a permanent J-code to avoid insurance delays still is to come and there have been formulary delays at academic centers, according to the note.RBC reiterated the company's stock rating at outperform, speculative risk, and rai","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4539","BK4007","LENZ","BK4139","VRDN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669237221","title":"Coinbase Flags AVAX Transfer Delays Ahead of Scheduled Avalanche Network Upgrade","url":"https://stock-news.laohu8.com/highlight/detail?id=2669237221","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669237221?lang=en_us&edition=fundamental","pubTime":"2026-09-22 23:40","pubTimestamp":1790091624,"startTime":"0","endTime":"0","summary":"BRIEF-Coinbase Flags AVAX Transfer Delays Ahead of Scheduled Avalanche Network UpgradeSept 22 (Reuters)-Coinbase Global IncCOIN.O:COINBASE: SOME USERS MAY EXPERIENCE DELAYS IN SENDS AND RECEIVES OF AVALANCHE (AVAX) DUE TO A SCHEDULED NETWORK UPGRADEFurther company coverage:COIN.O","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nFWN45E0G2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09711","IBLC","BK4112","BK4535","BK4595","BITQ","COIX","COIG","CONI","LU1861559042.SGD","BK4516","FDIG","LU1861217088.USD","07711","CONL","LU1861558580.USD","LU2360107671.USD","COIN","BLCK","COYY","09311","BK4596","COIA","COIW","FIAT","COII","BK4539","BK4588","BK4551","CONX","07311","FINX","BK4600","CONY","DAPP","BKCH","BK4554","ICOI","BK4585","AVAX.USD.CC","CRPT","LU1861220207.SGD","COIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669123216","title":"Coinbase: Some Users May Experience Delays in Sends and Receives of Avalanche (Avax) Due to a Scheduled Network Upgrade","url":"https://stock-news.laohu8.com/highlight/detail?id=2669123216","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669123216?lang=en_us&edition=fundamental","pubTime":"2026-09-22 23:37","pubTimestamp":1790091477,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nFWN45E0G2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4600","BK4588","BK4516","BK4595","07311","LU2360107671.USD","BK4554","09711","LU1861217088.USD","DAPP","07711","FINX","09311","LU1861558580.USD","COIN","BK4585","IBLC","LU1861220207.SGD","BK4596","COIX","FIAT","COIG","LU1861559042.SGD","COIW","BLCK","CONX","COIA","BK4112","AVAX.USD.CC","CONI","CONL","FDIG","ICOI","BKCH","BK4539","COIO","BK4535","COII","CRPT","COYY","CONY","BITQ","BK4551"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669397128","title":"RxSight is Maintained at Hold by Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2669397128","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669397128?lang=en_us&edition=fundamental","pubTime":"2026-09-22 22:23","pubTimestamp":1790086980,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/RXST/analyst-ratings","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","BK4539","RXST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669140799","title":"Qyuns Therapeutics Updates Board Composition and Governance Structure","url":"https://stock-news.laohu8.com/highlight/detail?id=2669140799","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669140799?lang=en_us&edition=fundamental","pubTime":"2026-09-22 22:08","pubTimestamp":1790086101,"startTime":"0","endTime":"0","summary":"Qyuns Therapeutics Co., Ltd. Class H ( ($HK:2509) ) has shared an update. Qyuns Therapeutics Co., Ltd. is a joint stock biopharmaceutical company i...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/qyuns-therapeutics-updates-board-composition-and-governance-structure?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/qyuns-therapeutics-updates-board-composition-and-governance-structure?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4139","BK4539","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669147753","title":"Qyuns Therapeutics Raises QX001S Deal Caps and Refreshes Board Line-Up","url":"https://stock-news.laohu8.com/highlight/detail?id=2669147753","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669147753?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:37","pubTimestamp":1790084237,"startTime":"0","endTime":"0","summary":"Qyuns Therapeutics Co., Ltd. Class H ( ($HK:2509) ) has issued an announcement. Qyuns Therapeutics plans to revise the annual caps for its QX001S f...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/qyuns-therapeutics-raises-qx001s-deal-caps-and-refreshes-board-line-up?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/qyuns-therapeutics-raises-qx001s-deal-caps-and-refreshes-board-line-up?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4007","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669147751","title":"IPOWER Stockholders Approve Capital and Incentive Changes","url":"https://stock-news.laohu8.com/highlight/detail?id=2669147751","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669147751?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:33","pubTimestamp":1790084010,"startTime":"0","endTime":"0","summary":"IPOWER ( ($IPW) ) has shared an announcement. On September 21, 2026, IPOWER held a special meeting of stockholders at which shareholders voted on t...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ipower-stockholders-approve-capital-and-incentive-changes?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ipower-stockholders-approve-capital-and-incentive-changes?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4104","BK4539","BK4122","IPW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669147818","title":"Global-E Online President Debbi Nir Disposes of 8,332 Common Shares Worth $307,385.61","url":"https://stock-news.laohu8.com/highlight/detail?id=2669147818","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669147818?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:15","pubTimestamp":1790082923,"startTime":"0","endTime":"0","summary":"Global-e Online President Debbi Nir disposes of 8,332 common shares worth $307,385.61Global-e Online President Debbi Nir sold 8,332 ordinary shares on Sep. 16, 2026 at a weighted average USD 36.89.Dir","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nNDL4gW7vz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Global-E Online President Debbi Nir Disposes of 8,332 Common Shares Worth $307,385.61","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4122","BK4588","BK4585","GLBE","BK4539","BK4220"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174429461","title":"Viking Therapeutics Surges Nearly 50% Premarket as Once-Every-Two-Week Dosing Retains 97% of Weight Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=1174429461","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174429461?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:00","pubTimestamp":1790082018,"startTime":"0","endTime":"0","summary":"Viking Therapeutics (VKTX.US) saw its shares spike nearly 50% in Tuesday's premarket trading after the biotech announced that its experimental obesity drug, VK2735, helped patients maintain most of...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MEDI","NVOX","LENZ","BK4599","VKTX","BK4539","XLVI","TRUH","IYH","BK4588","PJP","FXH","THNR","BK4007","NVOH","CURE","OZEM","FHLC","NBDS","BK4585","NVOC","RSPH","PINK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669295142","title":"Nexxen U Launches ‘Data for the Converged Media World,’ Building on Program Momentum and Industry Demand","url":"https://stock-news.laohu8.com/highlight/detail?id=2669295142","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669295142?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:00","pubTimestamp":1790082000,"startTime":"0","endTime":"0","summary":"Award-winning educational series helps media teams turn convergence into performance, leveraging expertise from Tastemade, Omnicom Media and A+ENEW YORK, Sept.  22, 2026 (GLOBE NEWSWIRE) -- Nexxen, th","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/22/3366380/0/en/nexxen-u-launches-data-for-the-converged-media-world-building-on-program-momentum-and-industry-demand.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NEXN","BK4539","BK4009"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669014400","title":"Forvis Mazars Capital Advisors Selects Intapp DealCloud with Celeste for Deal Workflow Automation","url":"https://stock-news.laohu8.com/highlight/detail?id=2669014400","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669014400?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:45","pubTimestamp":1790081116,"startTime":"0","endTime":"0","summary":"Forvis Mazars Capital Advisors selects Intapp DealCloud with Celeste for deal workflow automationIntapp reported Forvis Mazars Capital Advisors selected DealCloud with Celeste as part of a firmwide ag","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nNDLbqhxc8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","LU0757428866.USD","LU1815336091.USD","BK4539","BK4535","INTA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669614400","title":"Forvis Mazars Capital Advisors Selects Intapp Dealcloud with Celeste to Advance Firmwide Agentic AI Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2669614400","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669614400?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:45","pubTimestamp":1790081100,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nTUA9WBNY2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","LU0757428866.USD","LU1815336091.USD","BK4535","BK4023","INTA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669144752","title":"iPower Shareholders Approve $10 Million Common Stock Issuance at Special Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2669144752","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669144752?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:40","pubTimestamp":1790080852,"startTime":"0","endTime":"0","summary":"iPower shareholders approve $10 million common stock issuance at special meetingiPower held a special shareholder meeting on Sept. 21, 2026.Shareholders authorized issuance of up to $10 million of com","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nNDL1SWZ5k:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4104","BK4539","IPW","BK4122"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669461144","title":"BofA Adjusts Price Target on RxSight to $5.50 From $6.50","url":"https://stock-news.laohu8.com/highlight/detail?id=2669461144","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669461144?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:32","pubTimestamp":1790080354,"startTime":"0","endTime":"0","summary":"RxSight (RXST) has an average rating of hold and mean price target of $7.57, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and r","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RXST","BK4539","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669440191","title":"Aprea Therapeutics to Present Updated Interim Phase 1 Data on WEE1 Inhibitor APR-1051 in an Oral Presentation at 38th EORTC-NCI-AACR Symposium","url":"https://stock-news.laohu8.com/highlight/detail?id=2669440191","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669440191?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:30","pubTimestamp":1790080200,"startTime":"0","endTime":"0","summary":"DOYLESTOWN, Pa., Sept.  22, 2026 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage precision medicine oncology company focused on the discovery ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/22/3366342/0/en/aprea-therapeutics-to-present-updated-interim-phase-1-data-on-wee1-inhibitor-apr-1051-in-an-oral-presentation-at-38th-eortc-nci-aacr-symposium.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0572939691.SGD","BK1550","LENZ","01336","BK4139","LU0264606111.USD","BK4007","LU0572940350.SGD","BK1184","BK4539","BK1584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669144227","title":"Marker Therapeutics highlights expanded manufacturing support of CDMO partner","url":"https://stock-news.laohu8.com/highlight/detail?id=2669144227","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669144227?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:20","pubTimestamp":1790079621,"startTime":"0","endTime":"0","summary":"Marker Therapeutics (MRKR) highlighted the expanded infrastructure, technical expertise and manufacturing capabilities supporting its lead program,...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/marker-therapeutics-highlights-expanded-manufacturing-support-of-cdmo-partner-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/marker-therapeutics-highlights-expanded-manufacturing-support-of-cdmo-partner-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","LENZ","BK4007","CDMO","MRKR","BK4139","EES"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669410941","title":"Transcode Therapeutics - Announces Patent Advancements in Australia and Japan for Rna Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2669410941","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669410941?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:12","pubTimestamp":1790079148,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nFWN45E0D2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","RNAZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669141249","title":"Zeta Global Names Lalitha Stables President, UK","url":"https://stock-news.laohu8.com/highlight/detail?id=2669141249","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669141249?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:06","pubTimestamp":1790078800,"startTime":"0","endTime":"0","summary":"Zeta Global names Lalitha Stables president, UKZeta Global appointed Lalitha Stables as president of its U.K. business.Stables previously served as general manager and country manager, U.K., at HubSpo","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nNDL7X8bbn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZETA","IE00BFMHRM44.USD","BK4613","BK4023","ZETX","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669412441","title":"TransCode Therapeutics Says Australia Accepts Patent Application for siRNA Cancer Nanoparticle Delivery","url":"https://stock-news.laohu8.com/highlight/detail?id=2669412441","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669412441?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:06","pubTimestamp":1790078772,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics says Australia accepts patent application for siRNA cancer nanoparticle deliveryTransCode Therapeutics reported patent progress in Australia, citing acceptance of an application","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nNDL26Yw6T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","RNAZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669141407","title":"Zeta Global Invests in U.k. Growth with New London Hub and Leadership","url":"https://stock-news.laohu8.com/highlight/detail?id=2669141407","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669141407?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:05","pubTimestamp":1790078700,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nTUABKCBGH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ZETX","IE00BFMHRM44.USD","BK4539","BK4613","BK4023","ZETA"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":40,"pageCount":38,"totalSize":787,"code":"91000000","status":"200"}]}}